The Christie sees promise in HMBD-001 for bladder cancer
Early signals from an ongoing study at The Christie Hospital in Manchester shore up the evidence for an investigational treatment for the most common form of bladder cancer (urothelial carcinoma). The drug in the study – HMBD-001– is an anti-HER3 …